Indian J Pharm Close
 

Figure 2: Adaptive seamless phase II/III design (2a) and its comparison with classical Phase II and III trials (2b)

Figure 2: Adaptive seamless phase II/III design (2a) and its comparison with classical Phase II and III trials (2b)